Consistent with this, primary malignant rhabdoid tumors exhibit a gene expression profile of Hh-Gli activation, indicating that GLI1 drives the growth of SNF5-deficient malignant rhabdoid tumor cells both in vitro and in vivo. The gene discussed is GLI1; the disease is rhabdoid tumor.